| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.086 | 0.08 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.095 | 0.09 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.063 | 0.2 |